Login / Signup

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Pin GaoXiang WangYing JinWenquan HuYajun DuanAiping ShiYe DuDong SongMing YangSijie LiBing HanGang ZhaoHongquan ZhangZhimin FanQing Robert Miao
Published in: Breast cancer research : BCR (2018)
These results suggested that NgBR is a potential therapeutic target for increasing the sensitivity of ERα-positive breast cancer to tamoxifen.
Keyphrases
  • estrogen receptor
  • positive breast cancer
  • breast cancer cells
  • human health
  • binding protein
  • climate change